09-05-2025
Stifel Nicolaus Remains a Buy on Jamieson Wellness Inc (JWEL)
analyst Justin Keywood maintained a Buy rating on Jamieson Wellness Inc (JWEL – Research Report) today and set a price target of C$42.00.
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Keywood covers the Healthcare sector, focusing on stocks such as Knight Therapeutics, Andlauer Healthcare Group, and Cipher Pharmaceuticals. According to TipRanks, Keywood has an average return of -8.1% and a 38.20% success rate on recommended stocks.
Currently, the analyst consensus on Jamieson Wellness Inc is a Strong Buy with an average price target of C$41.60.
JWEL market cap is currently C$1.3B and has a P/E ratio of 24.99.
Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is neutral on the stock.
